RxDoctor Payments Data

Sylvia Garcia

Medical Oncology · Bayamon, PRNPI 1245234632

Payments from drug & device makers

$3,738in general payments, 2019–2025

Across 189 payments — averaging $19.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • E.r. Squibb & Sons, L.L.C.$979
  • Eli Lilly Export S.A. Puerto Rico Branch$588
  • Johnson & Johnson$465
  • Merck$403
  • AstraZeneca$337
  • AbbVie$278
  • plus $688 from 8 others

What the payments were for

  • Food & beverage$3,67398%
  • Education$652%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
E.r. Squibb & Sons, L.L.C.50$979
Eli Lilly Export S.A. Puerto Rico Branch30$588
Johnson & Johnson(2 entities)23$465
Merck21$403
AstraZeneca17$337
AbbVie12$278
Genentech USA, Inc.13$228
Amgen6$113
Sanofi5$102
Bayer4$82
PBG Puerto Rico LLC3$60
Pfizer Pharmaceuticals LLC2$41
Sanofi-aventis U.S. LLC2$38
Regeneron Healthcare Solutions, Inc.1$23

How this compares

Too few medical oncology providers in Puerto Ricoto place this figure against a meaningful peer group, so we don't.

Most prescribed under Part D

DrugClaimsCost to plans & patients
CalquenceAcalabrutinib Maleate12$183,678
Abiraterone Acetate13$45,651
ProliaDenosumab16$28,076
Ondansetron Hcl15$3,983
Anagrelide Hcl36$2,174
Hydroxyurea23$829
Anastrozole45$809
Exemestane14$706
Raloxifene Hcl15$294
Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip12$281
Letrozole14$177
Sodium Chloride0.9 % Sodium Chloride14$117
Prednisone16$79

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AstraZenecaCalquence$337$183,67812 claims
AmgenProlia$113$28,07616 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. There are too few medical oncology providers in Puerto Ricoon file to place this against a meaningful peer group, so we don't.

Other medical oncology in Bayamon

Where these figures come from

Is this you, or does something look wrong? →